Cutaneous Leishmaniasis Completed Phase 2 Trials for Pentavalent Antimony (DB13047)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01300975Intralesional Antimony for Bolivian Cutaneous LeishmaniasisTreatment
NCT00973128Reduced Doses of Antimony Plus Ranulocyte Monocyte Colony Stimulating Factor (GM-CSF) for Cutaneous LeishmaniasisTreatment